Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 13.48 | 28.60 | 11.61 | 6.20 |
Cashand Short Term Investments | 13.48 | 46.66 | 26.47 | 13.13 |
Accounts Receivable- Trade Net | 329.94 | 205.47 | 151.55 | 124.50 |
Total Receivables Net | 330.31 | 232.18 | 177.76 | 152.31 |
Total Inventory | 200.48 | 183.46 | 115.57 | 94.40 |
Other Current Assets Total | 56.20 | 0.86 | 0.10 | 0.16 |
Total Current Assets | 600.48 | 464.11 | 320.75 | 260.58 |
Property/ Plant/ Equipment Total- Net | 460.33 | 328.48 | 155.43 | 112.93 |
Intangibles Net | 5.62 | 0.68 | 0.61 | 0.45 |
Long Term Investments | 10.65 | 0.78 | 0.01 | 0.01 |
Note Receivable- Long Term | 0.41 | 56.25 | 34.57 | 17.12 |
Other Long Term Assets Total | 15.05 | 10.85 | 10.03 | 0.98 |
Total Assets | 1,092.54 | 861.16 | 521.40 | 392.06 |
Accounts Payable | 166.27 | 130.26 | 140.95 | 113.03 |
Current Portof LT Debt/ Capital Leases | 167.40 | 15.54 | 9.48 | 6.96 |
Other Currentliabilities Total | 38.38 | 30.33 | 29.14 | 27.06 |
Total Current Liabilities | 372.05 | 288.21 | 186.40 | 163.66 |
Long Term Debt | 153.96 | 190.40 | 47.40 | 34.93 |
Capital Lease Obligations | 11.56 | 16.49 | 0.91 | 3.32 |
Total Long Term Debt | 165.52 | 206.89 | 48.31 | 38.25 |
Total Debt | 332.92 | 334.19 | 64.39 | 61.54 |
Deferred Income Tax | 2.06 | 0.00 | 0.19 | 1.49 |
Other Liabilities Total | 20.35 | 18.25 | 17.39 | 15.22 |
Total Liabilities | 559.98 | 513.35 | 252.28 | 218.62 |
Common Stock Total | 10.03 | 9.69 | 9.69 | 9.69 |
Retained Earnings( Accumulated Deficit) | 522.53 | 338.11 | 259.42 | 163.74 |
Total Equity | 532.56 | 347.81 | 269.12 | 173.44 |
Total Liabilities Shareholders' Equity | 1,092.54 | 861.16 | 521.40 | 392.06 |
Total Common Shares Outstanding | 10.03 | 9.69 | 9.69 | 9.69 |
Tangible Book Valueper Share Common Eq | 52.55 | 35.81 | 27.70 | 17.84 |
Short Term Investments | - | 18.06 | 14.87 | 6.93 |
Prepaid Expenses | - | 0.95 | 0.85 | 0.58 |
Property/ Plant/ Equipment Total- Gross | - | 414.38 | 219.33 | 161.13 |
Accumulated Depreciation Total | - | -85.91 | -63.90 | -48.21 |
Goodwill Net | - | 0.00 | 0.00 | 0.00 |
Accrued Expenses | - | 0.31 | 0.23 | 0.28 |
Notes Payable/ Short Term Debt | - | 111.76 | 6.60 | 16.32 |
Gufic Biosciences Dividend Gufic Biosciences Bonus Gufic Biosciences News Gufic Biosciences AGM Gufic Biosciences Rights Gufic Biosciences Splits Gufic Biosciences Board Meetings Gufic Biosciences Key Metrics Gufic Biosciences Shareholdings Gufic Biosciences Profit Loss Gufic Biosciences Cashflow Gufic Biosciences Q1 Results Gufic Biosciences Q2 Results Gufic Biosciences Q3 Results Gufic Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks